Nanoparticles used in medical applications for the lung: Hopes for nanomedicine and fears for nanotoxicity

Journal of Physics: Conference Series

Volumn 304, Issue 1, 2011, Pages

  Boland, S ^a   Guadagnini, R ^a   Baeza Squiban, A ^a   Hussain, S ^a   Marano, F ^a  

^a Groupe Hospitalier Pitié Salpêtrière   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CONTROLLED DRUG DELIVERY; HEALTH HAZARDS; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NANOSTRUCTURED MATERIALS;

ADVERSE HEALTH EFFECTS; CONTROLLED RELEASE; FACILITATED TRANSPORT; NANO-DELIVERY SYSTEMS; NANOMETER SIZE; NANOTOXICOLOGY; POTENTIAL BENEFITS; POTENTIAL HEALTH;

TARGETED DRUG DELIVERY;

EID: 80052074949     PISSN: 17426588     EISSN: 17426596     Source Type: Conference Proceeding    
DOI: 10.1088/1742-6596/304/1/012031     Document Type: Conference Paper

References (62)

1. Wagner V, Dullaart A, Bock AK and Zweck A 2006 The emerging nanomedicine landscape. Nature Biotechnology 24 (10) October 1211-17
2. Allhoff F The Coming Era of Nanomedicine The American J. Bioethics 9 (10) 3-11
3. Card JW, Zeldin DC, Bonner JC, Nestmann ER 2008 Pulmonary applications and toxicity of engineered nanoparticles Am J Physiol Lung Cell Mol Physiol. 295 (3) L400-11
4. Smola M, Vandamme T, Sokolowski A 2008 Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases Int J Nanomedicine 3 (1) 1-19
5. Mansour HM, Rhee YS, Wu X 2009 Nanomedicine in pulmonary delivery. Int J Nanomedicine 4 299-319
6. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA, Billon-Galland MA, Fleury-Feith J, Moisan F, Pairon JC, Marano F 2009 Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount Toxicology 16 (260(1-3) 142-9
7. Tanaka M, Nyce JW 2001 Respirable antisense oligonucleotides: a new drug class for respiratory disease Respir Res. 2 (1) 5-9
8. Yamagata T, Ichinose M Agents against cytokine synthesis or receptors 2006 Eur J Pharmacol 8 (533(1-3) 289-301
9. Li L, Das AM, Torphy TJ, Griswold DE 2002 What's in the pipeline? Prospects for monoclonal antibodies (mAbs) as therapies for lung diseases. Pulm Pharmacol Ther 15 (5) 409-16
10. Gill DR, Bazzani RP, Hyde SC 2010 Strategies for long-term expression of transgenes in the respiratory epithelium. Curr Opin Mol Ther 12 (4) 386-93
11. Sanders N, Rudolph C, Braeckmans K, De Smedt SC, Demeester J 2009 Extracellular barriers in respiratory gene therapy. Adv Drug Deliv Rev. 27 (61(2) 115-27
12. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A and Stark WJ 2007 Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 41 4158-63
13. Oberdörster G, Oberdörster E, Oberdörster J 2005 Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113 (7) 823-39
14. Semmler-Behnke M, Kreyling W, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid G, Brandau W 2008 Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4 (12) 2108-11
15. Kreyling W, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A 2002 Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low J Toxicol Environ Health A 65 (20) 1513-30
16. Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdörster G, Kreyling W 2007 Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect 115 (5) 728-33
17. Chen J, Tan M, Nemmar A, Song W, Dong M, Zhang G, Li Y 2006 Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology 222 (3) 195-201
18. Meiring J, Borm P, Bagate K, Semmler M, Seitz J, Takenaka S, Kreyling W 2005 The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol 2 3
19. Yacobi N, Demaio L, Xie J, Hamm-Alvarez S, Borok Z, Kim K, Crandall E 2008 Polystyrene nanoparticle trafficking across alveolar epithelium. Nanomedicine 4 (2) 139-45
20. Furuyama A, Kanno S, Kobayashi T, Hirano S 2009 Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage- associated routes. Arch Toxicol 83 (5) 429-37
21. Pandey R, Zahoor A, Sharma S, Khuller GK 2003 Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis Tuberculosis (Edinb) 83 (6) 373-8
22. Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T 1999 Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect J Control Release 1 (62(1-2) 279-87
23. Zhang Q, Shen Z, Nagai T 2001 Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats Int J Pharm 7 (218(1-2) 75-80
24. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W 2008 The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles Am J Respir Cell Mol Biol 38 (3) 371-6
25. Church LD, McDermott MF 2009 Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther 11 (1) 81-9
26. Barnes PJ 2003 Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev 14 (6) 511-22
27. Mahler DA, Huang S, Tabrizi M, Bell GM 2004 Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. Chest 126 (3) 926-34
28. Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Siler T, Snell P, Korenblat P, Smith W, Kaye M, Mandel M, Andrews C, Prabhu R, Donohue JF, Watt R, Lo KH, Schlenker-Herceg R, Barnathan ES, Murray J 2007 The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 1 (175(9) 926-34
29. Dentener MA, Creutzberg EC, Pennings HJ, Rijkers GT, Mercken E, Wouters EF 2008 Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration 76 (3) 275-82
30. Van der Vaart H, Koter GH, Postma DS, Kauffman HF, ten Hacken NH 2005 First study of infliximab treatment in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 15 (172(4) 465-9
31. Woodruff PG, Wolff M, Hohlfeld JM, Krug N, Dransfield MT, Sutherland ER, Criner GJ, Kim V, Prasse A, Nivens MC, Tetzlaff K, Heilker R, Fahy JV 2010 Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease Am J Respir Crit Care Med 1 (181(5) 438-45
32. Baeza A, Boland S, Hussain S, Marano F 2011 Health effects of nanoparticles Systems Toxicology : from omics technology to nanotechnology (John Wiley and Sons Ltd)
33. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI 2004 Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol.Sci. 77 (2) 347-357
34. Elder A, Gelein R, Finkelstein JN, Driscoll KE, Harkema J, Oberdorster G 2005 Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol.Sci. 88 (2) 614-629
35. Grassian VH, O'Shaughnessy PT, Mcakova-Dodd A, Pettibone JM, Thorne PS 2007 Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ.Health Perspect. 115 (3) 397-402
36. Warheit DB, Webb TR, Reed KL 2006 Pulmonary toxicity screening studies in male rats with TiO2 particulates substantially encapsulated with pyrogenically deposited, amorphous silica. Part Fibre.Toxicol. 3 3
37. Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM 2007 Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology 230 (1) 90-104
38. Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL 2006b Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol.Sci. 91 (1) 227-236
39. Lam CW, James JT, McCluskey R, Hunter RL 2004 Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol.Sci. 77 (1) 126-134
40. Mercer RR, Scabilloni J, Wang L, Kisin E, Murray AR, Schwegler-Berry D, Shvedova AA, Castranova V 2008 Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am.J.Physiol Lung Cell Mol.Physiol 294 (1) L87-L97
41. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR 2004 Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol.Sci. 77 (1) 117-125
42. Alessandrini F, Schulz H, Takenaka S, Lentner B, Karg E, Behrendt H, Jakob T 2006 Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung J.Allergy Clin.Immunol. 117 (4) 824-830
43. Inoue K, Takano H, Yanagisawa R, Koike E, Shimada A 2009 Size effects of latex nanomaterials on lung inflammation in mice. Toxicol.Appl.Pharmacol. 234 (1) 68-76
44. Inoue K, Takano H, Yanagisawa R, Sakurai M, Abe S, Yoshino S, Yamaki K, Yoshikawa T 2007 Effects of nanoparticles on lung physiology in the presence or absence of antigen. Int.J.Immunopathol.Pharmacol. 20 (4) 737-744
45. Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, Martens JA, Dinsdale D, Boland S, Marano F, Nemery B, Hoet PH 2010 Lung exposure to nanoparticles modulates an asthmatic response in a mouse model of asthma. Eur Respir J. 6 11
46. Nygaard UC, Samuelsen M, Aase A, Lovik M 2004 The capacity of particles to increase allergic sensitization is predicted by particle number and surface area, not by particle mass. Toxicol.Sci. 82 (2) 515-524
47. Takenaka S, Karg E, Kreyling WG, Lentner B, Schulz H, Ziesenis A, Schramel P, Heyder J 2004 Fate and toxic effects of inhaled ultrafine cadmium oxide particles in the rat lung. Inhal Toxicol. 16 (Suppl 1) 83-92
48. Farkas A, Balshzy I, Szocs K 2006 Characterization of regional and local deposition of inhaled aerosol drugs in the respiratory system by computational fluid and particle dynamics methods. J Aerosol Med. 19 (3) 329-43
49. Anderson PJ, Wilson JD, Hiller FC 1990 Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest. 97 (5) 1115-20
50. Roller M 2009 Carcinogenicity of inhaled nanoparticles. Inhal.Toxicol. 21 (S1) 144-157
51. Schins RP, Knaapen AM 2007 Genotoxicity of poorly soluble particles. Inhal.Toxicol. 19 (Suppl 1) 189-198
52. Nel A, Xia T, Mädler L, Li N 2006 Toxic potential of materials at the nanolevel. Science 311 (5761) 622-7
53. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh J, Wiesner M, Nel A 2006 Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6 (8) 1794-807
54. Hoet P, Nemmar A, Nemery B 2004 Health impact of nanomaterials? Nat Biotechnol 22 (1) 19
55. Donaldson K, Borm PJ, Castranova V, Gulumian M 2009 The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles. Part Fibre Toxicol. 27 (6) 13
56. Marano F, Hussain S, Rodrigues-Lima F, Baeza-Squiban A, Boland S 2010 Nanoparticles: molecular targets and cell signalling. Arch Toxicol. 5 26
57. Möller W, Brown D, Kreyling W, Stone V 2005 Ultrafine particles cause cytoskeletal dysfunctions in macrophages: role of intracellular calcium. Part Fibre Toxicol 2 7
58. Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W, Simon U, Jahnen- Dechent W 2009 Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5 (18) 2067-76
59. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W 2007 Size-dependent cytotoxicity of gold nanoparticles. Small 3 (11) 1941-9
60. Sydlik U, Bierhals K, Soufi M, Abel J, Schins R, Unfried K 2006 Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using EGF-R. Am J Physiol Lung Cell Mol Physiol 291 (4) L725-33
61. 2 nanoparticles: studies on a human monoblastoid cell line. Toxicol In Vitro 22 (7) 1689-96
62. Hussain S, Thomassen LC, Ferecatu I, Borot MC, Andreau K, Martens JA, Fleury J, Baeza-Squiban A, Marano F, Boland S 2010 Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells Part Fibre Toxicol. 16 (7) 10